Phytanic acid, a metabolite of the chlorophyll molecule, is part of the human diet and is present in normal human serum at low micromolar concentrations. It was previously shown to be a ligand of the 9-cis-retinoic acid receptor and peroxisome proliferator-activated receptor (PPAR) α. PPAR agonists are widely used in the treatment of type 2 diabetes. Here, we report that phytanic acid is not only a transactivator of PPARα, but it also acts via PPARβ and PPARγ in CV-1 cells that have been cotransfected with the respective full-length receptor and an acyl-CoA oxidase-PPAR-responsive element-luciferase construct. We observed that, in contrast to other fatty acids, phytanic acid at physiological concentrations enhances uptake of 2-deoxy-D-glucose in rat primary hepatocytes. This result could be explained by the increase in mRNA expression of glucose transporters-1 and -2 and glucokinase, as determined by quantitative real-time reverse transcriptase-polymerase chain reaction. Compared with the PPARγ-specific agonist ciglitazone, phytanic acid exerts only minor effects on the differentiation of C3H10T1/2 cells into mature adipocytes. These results clearly demonstrate that phytanic acid acts via different PPAR isoforms to modulate expression of genes involved in glucose metabolism, thus suggesting a potential role of phytanic acid in the management of insulin resistance.
T he human diet contains phytol, a metabolite of the chlorophyll molecule. As chlorophyll is cleaved by microorganisms in the digestive tract of ruminants, dairy products, together with liver oil from fish, are the major sources of phytol (1) . In the human body, absorbed phytol is metabolized to the branched chain fatty acids-phytenic acid and phytanic acid [(3RS,7R,11R)-tetramethylhexadecanoic acid]. Phytenic acid and phytanic acid levels in normal human serum are 2 and 6 µM, respectively (2) . Phytanic acid levels may be elevated more than 50-fold in patients with heredopathia atactica polyneuritiformis (Refsum disease), an inherited metabolic disorder characterized by an α-hydroxylase gene defect that prevents the conversion of phytanic acid to pristanic acid (Fig. 1A) [reviewed by Verhoeven et al. (3) ].
In adult mice fed a 0.5% phytol diet for 21 days, a 40% decrease in the serum triglyceride levels was noted, but serum cholesterol levels remained unaffected (4) . Moreover, the expression of enzymes known to be involved in beta-oxidation and regulated by the peroxisome proliferatoractivated receptor (PPAR) were up-regulated. In addition, it has been shown that phytanic acid is a 9-cis-retinoic acid receptor (RXR) ligand as well as a PPARα ligand (5) (6) (7) (8) . RXR receptor binding and transcriptional effects were observed with EC 50 and IC 50 values of 3 and 2.3 µM, respectively. The K d value for phytanic acid as a PPARα ligand is reported as 10 nM (8) . Concentration-dependent activation of PPARα by phytanic acid and pristanic acid (EC 50 40 µM) was observed in COS-1 cells transiently transfected with PPARα and a PPAR-responsive element (PPRE)-luciferase reporter construct (9) . In contrast to the ability of 9-cis-retinoic acid to activate both RXR and the all-trans-retinoic acid receptor (EC 50 2.5 nM and IC 50 13 nM), phytanic acid activity is restricted to RXR receptors.
Activation of both PPAR and RXR by phytanic acid and its specificity for retinoid receptors and PPAR isoforms may lead to a distinct pattern of gene induction that differs from the pattern observed with other fatty acids.
Activation of PPARγ by antidiabetic thiazolidinediones such as ciglitazone, troglitazone, rosiglitazone, and pioglitazone can lead to restored insulin sensitivity in type 2 diabetes in animals and humans (10, 11) . It was recently suggested that phytanic acid as a RXR ligand could also affect PPARγ and might therefore be useful in the prevention and treatment of this metabolic disorder (12) .
In addition to skeletal muscle and white adipose tissue, the liver is an important tissue in glucose homeostasis. Furthermore, as the expression of PPARα and PPARγ has been shown in rodent and human liver (13) (14) (15) (16) , one could expect that the transcription of enzymes involved in glucose homeostasis is activated in hepatocytes by phytanic acid.
In this study, we investigated the effect of phytanic acid on glucose uptake in primary rat hepatocytes and the transcriptional regulation of three major enzymes involved in that process, namely, glucose transporters GLUT1 and GLUT2 and glucokinase. As there is still little known about the transactivational activity of phytanic acid on PPARs, we explored the agonistic potential of phytanic acid on full-length human PPARα, -β, and -γ by using a luciferase-based transactivation assay in the monkey kidney cell line CV-1. Because PPARγ-specific agonists are strong inducers of adipogenesis, we also investigated the differentiation potential of phytanic acid in comparison to isoform-specific agonists in a preadipocyte cell culture model.
MATERIALS AND METHODS

Materials
Cell culture media and FCS were purchased from Life Technologies, Gaithersburg, MD, and the fatty acid-free artificial serum supplement (BMS) was from Biochrom KG, Berlin, Germany. All isomers of phytol and phytanic acid were kindly provided by Dave Burdick, Roche Vitamins, Basel, Switzerland. Prostaglandin A 1 (PGA 1 ), WY-14643, and ciglitazone were purchased from Anawa Trading SA, Wangen, Switzerland. Additional compounds were obtained from SigmaAldrich, Buchs, Switzerland, if not indicated otherwise. Polymerase chain reaction (PCR) primers were purchased from Life Technologies, and TaqMan probes were purchased from Integrated DNA Technologies, Coralville, IA, or PE Biosystems, Foster City, CA.
Cell culture
CV-1 and C3H10T1/2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) FCS and 2 mM L-glutamine (standard medium). Both cell lines were cultured in 75-cm 2 tissue culture flasks at 37°C in 95% air-5% CO 2 with a relative humidity of 95%.
Primary rat hepatocytes were obtained by a two-step liver perfusion, and cells were subsequently seeded in 6-or 24-well plates and left to attach for 3 h, as previously described (17) . Medium was then changed to a fatty acid-free medium (Ham F12 supplemented with 10% BMS), and cells were stimulated in a time-and dose-dependent manner with phytanic acid, palmitic acid, or docosahexaenoic acid (DHA).
Expression and reporter plasmids
The plasmids pSG-PPARα, -β, and -γ, expressing human PPARα, -β and -γ1, respectively, were kindly provided by Roger Clerc and Markus Meyer, F. Hoffmann-La Roche, Basel, Switzerland. The plasmids were constructed by cloning full-length coding sequences of the pertinent receptors into the pSG5 expression vector. The (ACO-PPRE) 4 -tk-luc reporter plasmid was kindly provided by Hugo Stirnimann, Roche Vitamins, Basel, Switzerland. Four repeats of the PPRE from the acyl-CoA oxidase (ACO) gene promotor (CCGGACCAGGACAAAGGTCA) followed by a tk minimal promoter were cloned into the pGL-3 basic vector.
Transient transfection and reporter gene assays
Cells were transiently transfected by using LipofectAMINE 2000 Reagent in Opti-MEM Ι (both from Life Technologies). After 24 h of incubation, cells were trypsinized, and 75-µl aliquots of the cell suspension in DMEM supplemented with 0.1% (w/v) fatty acid-free bovine serum albumin and 2 mM L-glutamine (stimulation medium) (~25,000 cells) were then added per well to an opaque 96-well tissue culture plate and incubated for 4-5 h to allow the cells time to adhere to the bottom of the wells. To stimulate the cells, 25 µl of 4× concentrated ligands in stimulation medium was added to each well, in triplicate, and the plate was incubated for 24 h.
To assay the luciferase activity on each plate, 75 µl of Steady-Glo Luciferase Buffer (Promega, Madison, WI) was added to each well. The plate was incubated for 15 min at room temperature on a plate shaker before the luminescence was measured for 5 s per well with a Luminoskan luminescence reader (Labsystems, Helsinki, Finland).
2-Deoxy-D-glucose uptake
Rat primary hepatocytes cultured in 24-well plates were treated for 24 h with phytanic acid, palmitic acid, and DHA (100 µM each). Subsequently, the medium was removed and cells were washed twice with prewarmed PBS, pH 7.4. Samples of 500 µl of prewarmed glucose reaction mixture (0.01 mM 2-deoxy-D-glucose and 3 µCi/ml [ 3 H]2-deoxy-D-glucose in PBS) were then added to the cells. The reaction mixture was further incubated at 37°C for different time intervals. The reaction was terminated by aspirating the reaction mixture and washing the cells twice with ice-cold 10 mM 2-deoxy-D-glucose in PBS. Cells were then solubilized with 500 µl of 1% sodium dodecyl sulfate, 400 µl of which was transferred to scintillation vials containing 5 ml of Quickszint 1 (Zinsser Analytic, Frankfurt, Germany). Radioactivity was counted in a Tri-Carb 2500 (Packard, Meriden, CT) liquid scintillation counter. The remaining lysate was used for protein content determination with the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). Data are expressed as means ± SD from three independent experiments.
Adipocyte differentiation
The mouse embryo fibroblast cell line C3H10T1/2 (18) was used for adipocyte differentiation. Cells were seeded at a density of 20,000 cells/cm 2 into 6-well tissue culture plates and were grown to confluency (~2 days) in standard medium with 5% CO 2 at 37°C. Two days after confluency was reached, differentiation was induced by adding 3 ml of induction medium (standard medium supplemented with 200 nM insulin plus test compound). Control wells received vehicle and 200 nM insulin alone. Medium was changed every 48 h up to 120 h, after which the induction medium was replaced with standard medium for the next 48 h. The cells were then used for either RNA extraction or oil red O staining.
Oil red O staining
Culture medium was aspirated, the cells were washed twice with 1× PBS, and cells were then fixed by adding 1 ml of ice-cold 60% isopropanol in 1× PBS for 5 min at room temperature. Fixing solution was aspirated, and 1 ml of 0.24% (w/v) oil red O in 60% isopropanol was added. The cells were incubated for 30 min at room temperature in the presence of the stain. The stain was removed, and the cells were washed twice with 1× PBS before being viewed and photographed.
Quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
For quantification of gene expression levels, we utilized a real-time quantitative TaqMan RT-PCR assay based on the multiplex method. Briefly, total RNA was isolated using the RNeasy kit from QIAGEN (Valencia, CA). The first-strand cDNA was synthesized in a 20-µl reaction from 5 µg of total RNA by reverse transcription with SuperScript II (Life Technologies) using 100 ng random hexamers, as previously described (19) . Subsequently, the cDNA was diluted to 500 µl in diethylpyrocarbonate-treated water. In a 50-µl reaction, 10 µl of cDNA was amplified in the 7700 Sequence Detector (PE Biosystems), using the 2× Universal Master Mix (PE Biosystems), and the following PCR primers and TaqMan probes at concentrations of 300 and 100 nM, respectively: facilitative glucose transporter GLUT1 (5'-GGT TCA TCA TCA GCA TGG AGT TC-3', 5'-GGG CAT GAT TGG TTC CTT CTC-3', and 5'-FAM-CCT GCC AAA GCG ATT AAC AAA GAG GCC-Tamra-3'), GLUT2 (5'-CGC CCT CTG CTT CCA GTA CA-3', 5'-AGG ACC ACC CCA GCA AAA A-3', and 5'-FAM-CGG ACT TCC TCG GGC CTT ACG TGTTamra-3'), glucokinase (5'-CGT GGA TGG CTC CGT GTA C-3', 5'-TGT CAG CCT GCG CAC ACT-3', and 5'-FAM-AGC TGC ACC CGA GCT TCA AGG AGC-Tamra-3'), adipocyte fatty acid binding protein aP2 (5'-GCG TGG AAT TCG ATG AAA TCA-3', 5'-CCC GCC ATC TAG GGT TAT GA-3', and 5'-FAM-CGC AGA CGA CAG GAA GGT GAA GAG C-Tamra-3'), lipoprotein lipase (LPL) (5'-GTG GCC GAG AGC GAG AAC-3', 5'-AAG AAG GAG TAG GTT TTA TTT GTG GAA-3', and 5'-FAM-TTC CCT TCA CCC TGC CCG AGG -Tamra-3'), PPARγ2 (5'-CTA TGA GCA CTT CAC AAG AAA TTA CCA T-3', 5'-TCC ATC ACG GAG AGG TCC AC-3', and 5'-FAM-TCT GGC CCA CCA ACT TCG GAA TCA G-Tamra-3') and the reference genes β-actin (5'-GAC AGG ATG CAG AGG AGA TTA CTG-3', 5'-CCA CCG ATC CAC ACA GAG TAC TT-3', and 5'-VIC-TCA AGA TCA TTG CTC CTC CTG AGC GCTamra-3') and 18S rRNA (5'-CGG CTA CCA CAT CCA AGG AA-3', 5'-GCT GGA ATT ACC GCG GCT-3', and 5'-VIC-TGC TGG CAC CAG ACT TGC CCT C-Tamra-3') at primer and probe concentrations of 50 nM. Induction of gene expression and corresponding error bars were calculated from three independent experiments by using the ∆CT method according to the manufacturer's protocol.
RESULTS
Transcriptional activation of PPAR isoforms by phytanic acid in CV-1 cells
We investigated the transactivational effect of phytanic acid and its natural stereomers on the (ACO-PPRE) 4 -tk-luc construct, cotransfected with the human PPAR isoforms α, β, and γ in CV-1 cells. Endogenous ACO gene expression and expression of comparable reporter constructs have previously been shown to be activated by PPARs in a ligand-dependent manner (20) . No effect on cell viability was observed in all cell lines used on treatment with up to 300 µM phytanic acid for 24 h (data not shown).
Stimulation of CV-1 cells for 24-h with 30 µM phytanic acid revealed significant stimulation of luciferase activity in cells cotransfected with pSG-PPARα, -β, or -γ; whereas the phytanic acid precursors trans-or cis-phytol had no or very low transactivational potential (Fig. 2) . Phytanic acid showed a stronger selectivity toward PPARα and PPARγ compared with PPARβ. Results of (3RS,7R,11R)-phytanic acid treatment were compared with those obtained from treatment with palmitic acid and DHA as well as the ligands WY-14643, PGA 1 , and ciglitazone (Fig. 1B) , which are specific for the receptor isoforms PPARα, PPARβ, and PPARγ respectively (Fig. 2) . Dose-dependent stimulation of the PPAR isoforms with (3R,7R,11R)-or (3S,7R,11R)-phytanic acid revealed no significant difference in transactivation as compared with the mixture thereof (Fig. 3) .
Glucose uptake
The use of glucose as a substrate does not reflect the true kinetics of transport because it is readily metabolized, and transport may not necessarily be rate limiting. Therefore, we used the nonmetabolizable glucose analogue 2-deoxy-D-glucose in our assay.
Measurement of 2-deoxy-D-glucose uptake in cultures of primary rat hepatocytes during the time course of study revealed a substantial increase in 2-deoxy-D-glucose uptake in hepatocytes treated with 100 µM (3RS,7R,11R)-phytanic acid as compared with the vehicle control, 100 µM palmitic acid, or 100 µM DHA (Fig. 4A) .
mRNA expression in hepatocytes in response to phytanic acid
To see whether genes involved in hepatic glucose uptake were regulated by phytanic acid, mRNA expression for GLUT1, GLUT2, and glucokinase was investigated in primary rat hepatocytes. mRNA levels of the reference genes encoding for: β-actin, glyceraldehyde-3-phosphate dehydrogenase, hypoxanthine phosphoribosyltransferase, and 18S ribosomal RNA were compared in cells treated for 24 h with or without 100 µM (3RS,7R,11R)-phytanic acid. As mRNA levels of β-actin and 18S ribosomal RNA were not affected by phytanic acid, all results were normalized to β-actin mRNA levels. mRNA levels of GLUT2 and glucokinase were found to be maximal after a 24-h stimulation period with (3RS,7R,11R)-phytanic acid. A 2.2-fold (range 1.6-2.9) and 2.4-fold (range 1.7-3.3) induction of mRNA levels for GLUT1 was observed in hepatocytes stimulated for 24 h with 100 µM (3RS,7R,11R)-phytanic and palmitic acid, respectively (Fig. 4B) . Lower (3RS,7R,11R)-phytanic and palmitic acid concentrations (data not shown) and DHA concentrations of up to 100 µM did not affect GLUT1 mRNA levels. Treatment of the cells for 24 h with 100 µM (3RS,7R,11R)-phytanic acid resulted in a 3.2-fold (range 2.7-3.8) increase in GLUT2 mRNA levels (Fig. 4B) . In comparison, palmitic acid and DHA did not affect GLUT2 mRNA expression. The mRNA level of glucokinase was induced by 100 µM (3RS,7R,11R)-phytanic acid 3.0-fold (range 2.5-3.4) but was slightly reduced by 100 µM palmitic acid and DHA.
Adipocyte differentiation
To investigate whether phytanic acid can differentiate preadipocytic precursor cells because of its PPARγ activity into lipid-accumulating adipocytes, mouse embryo fibroblast cells C3H10T1/2 were used. Cells were treated with insulin in the absence or presence of 50 µM ciglitazone, 50 µM WY-14643, or 50 µM (3RS,7R,11R)-phytanic acid. In cultures treated with ciglitazone, a large number of cells changed morphology toward adipocytes with lipidaccumulating droplets (Fig. 5C ). In contrast, very few adipocytes were found in cultures treated with (3RS,7R,11R)-phytanic acid. Moreover, these adipocytes were observed to be markedly smaller than adipocytes differentiated by ciglitazone (Fig. 5D) . WY-14643-treated cells (Fig. 5B) were indistinguishable from vehicle-stimulated cells (Fig. 5A) . (Fig.  6 ).
DISCUSSION
Liver, second to skeletal muscle and white adipose tissue, plays a crucial role in glucose metabolism and is therefore an important regulator of glucose levels in plasma. The data presented in this paper demonstrate that glucose uptake in primary cultures of rat hepatocytes is markedly induced by concentrations of phytanic acid at one order of magnitude higher than normal human serum levels. The enzymes involved in glucose uptake that we examined are two members of the facilitative glucose transporter family [for review see Olson and Pessin (21)] and glucokinase. An up-regulation of both GLUT1 and GLUT2 mRNA levels was observed, paralleled by an increase in 2-deoxy-D-glucose uptake. In primary rat hepatocyte cultures, mRNA for GLUT4, the main glucose transporter in skeletal muscle, was not detectable. The liver-type glucose transporter, GLUT2, is distinguished from other GLUT isoforms by being a low-affinity glucose transporter with a high turnover rate (22) . The presence of a low-affinity glucose transporter ensures that, in liver cells, the glucose flux will be directly proportional to the glucose gradient across the cell membrane. Moreover, in hepatocytes, GLUT2 is coupled with the regulated phosphorylation activity of glucokinase. During states of glycogen synthesis, glucokinase is up-regulated and can increase the formation of intracellular glucose 6-phosphate, while a low intracellular concentration of free glucose is maintained (23) . Recent studies emphasize the critical role of glucokinase in the tight regulation of glucose uptake, storage, and gluconeogenesis [reviewed in Radziuk and Pye (24) ]. Consequently, paralleled up-regulation of GLUT2 and glucokinase must have a synergistic effect on plasma glucose clearing in the liver. Phytanic acid was previously described as a ligand for both RXR and PPARα (5-9). The results from our study show that phytanic acid also exerts a certain promiscuity in transactivating PPARβ and PPARγ. This transactivation potential is unique compared with other fatty acids and with the phytanic acid precursors used in our assays. With the findings that the GLUT2 gene is regulated by a PPRE (25) and that liver glucokinase mRNA is induced in Zucker diabetic fatty rats by a PPARγ agonist (26), a PPAR-mediated mechanism may explain the observed glucose influx in hepatocytes treated with phytanic acid.
PPAR forms permissive heterodimers with RXR, meaning that either partner can regulate the transcriptional activity by interacting with its own ligand. Cotreatment of cells with ligands for PPAR as well as RXR results in an additive effect (27) . Moreover, it was shown that ligands selective for RXR can activate PPRE-driven reporter genes (28) (29) (30) . In vivo sensitization to insulin was demonstrated in diabetic and obese mice in response to RXR agonists, comparable to the effects observed with thiazolidinediones (31) . It was recently shown in experimental animal models for impaired glucose tolerance that compounds with dual PPARα and PPARγ activities have blood glucose-and triglyceride-lowering properties (32; 33) . Furthermore, as noted in our study, the ability of phytanic acid to activate RXR as well as PPARα and PPARγ would explain the expression of a specific set of genes. The property of phytanic acid as a nonspecific agonist of different nuclear receptors is also reflected in the limited potential to differentiate C3H10T1/2 cells into mature lipid-accumulating adipocytes. It is well known that highly selective PPARγ agonists are extremely powerful in differentiating mesenchymal precursors into mature adipocytes (34) (35) (36) .
In conclusion, we have shown that, in contrast to other fatty acids, phytanic acid is able to enhance glucose uptake in hepatocytes without strongly promoting adipogenic differentiation. Specifically, phytanic acid differs from palmitic acid and DHA in its potential to up-regulate both the glucose transporters and glucokinase, resulting in increased glucose uptake in primary rat hepatocytes. These effects may be explained by the observation that phytanic acid, at physiological concentrations, is acting via both PPARα and PPARγ, thereby activating the transcription of a distinct pattern of genes that favors glucose uptake. In conclusion, we postulate that phytanic acid, a naturally occurring compound that is part of the human diet, may have a potential role in the management of insulin resistance. 
